The regular assessment of temporal change in symptoms of children with Autism Spectrum Disorder (ASD) participating in a clinical trial has been a long-standing challenge. A common hurdle in these efforts is the availability of trained technicians needed to conduct rigorous and consistent assessment of children at multiple time points. If parents could administer regular psychometric evaluations of their children, then the cost of clinical trials will be reduced, enabling longer clinical trials with the larger number of subjects.
The ATEC was developed to provide such a free and easily accessible method for caregivers to track the changes of ASD symptoms over time (Rimland and Edelson 1999). Various studies have sought to confirm the validity and reliability of ATEC (Al Backer 2016; Geier et al. 2013; Jarusiewicz 2002), yet none to date have assessed longitudinal changes in participants’ ATEC scores with respect to age, sex, and ASD severity. One trial conducted by Magiati et al., aimed to comprehensively assess ATEC’s ability to longitudinally measure changes in participant performance (Magiati et al. 2011). That study utilized ATEC to monitor the progress of 22 schoolchildren over a 5-year period. ATEC score was compared to age-specific cognitive, language, and behavioral metrics such as the Wechsler Preschool and Primary Scale of Intelligence. The researchers noted ATEC’s high level of internal consistency as well as a high correlation with other standardized assessments used to measure the same capacities in children with ASD (Magiati et al. 2011). Charman et al. utilized ATEC amongst other measures to test the feasibility of tracking the longitudinal changes in children using caregiver-administered questionnaires and noted differential effects across subscales of ATEC, possibly driven by development-focused vs. symptom-focused subscales that are conflated in the ATEC total score (Charman et al. 2004). Another study assessing the ability of dietary intervention to affect ASD symptoms also utilized ATEC as a primary measure (Klaveness et al. 2013), concluding that it has “high general reliability” coupled with an ease of access. Whitehouse et al. used ATEC as a primary outcome measure for a randomized controlled trial of their iPad-based intervention for ASD named TOBY (Whitehouse et al. 2017). This trial was conducted over a 6-month time frame, with outcome assessments at the 3- and 6-month time points. Although the study did not demonstrate significant ATEC score differences amongst test groups, the researchers reaffirmed their use of ATEC, noting its “internal consistency and adequate predictive validity” (Whitehouse et al. 2017). These studies support the viability of ATEC as a tool for longitudinal measurement of ASD severity which can be vital in tracking symptom changes during a trial.
The current study analyzed data reported by participants using the online version ATEC over a 4-year time period from 2013 to 2017. Assessing these data permitted insight into the effects of age, sex, country of origin, and ASD severity on the longitudinal changes in ATEC score with all of these factors (save for sex) showing statistically significant differences affecting ATEC score dynamics. These findings identify specific variables capable of altering the developmental trajectory of children with ASD and indicate possible avenues of future investigation of causal relationships related to changes in ASD severity.
Sex Does Not Affect ATEC Score
The prevalence of ASD is strongly male-biased, affecting four times as many males as females. Accordingly, we were interested in differences in the rate of improvement between participants of different sexes. No significant differences in improvement of ATEC total score were observed. This suggests that the rate of improvement of ASD symptoms remains similar in males and females.
Effect of Age on ATEC Score
The participants’ age was a significant modulating factor in determining the rate of their improvement. Younger children demonstrated greater improvement in ATEC total score. This phenomenon was recapitulated across subscales, with differences between the 2–3 YOA group and 3–6 YOA group reaching statistical significance for the Communication, Sociability, and Physical subscales and differences between the 2–3 YOA group and 6–12 YOA group reaching statistical significance for all subscales (Table 6). This finding is consistent with other ATEC longitudinal studies: younger children showed greater improvement in ATEC total score compared to the older children (Magiati et al., Charman et al., Whitehouse et al., Table 14).
Table 14 Comparison of the annualized decrease of ATEC score across multiple studies
The magnitude of the annual decrease of the ATEC score was also found to be roughly similar to other reports across the studied age range. For the younger children the reduction of ATEC score seen in this study is in between those of Whitehouse et al./TOBY trial and Charman et al., Table 14. For the older children, the reduction of ATEC seen in this study is somewhat similar to that reported by Charman et al., Table 14.
The small differences between the studies can be attributed to differences in study design. In particular, the current study (1) had significantly more participants, (2) was based on greater number of ATEC evaluations, and (3) was conducted over the longer period of time than all the others discussed herein.
Effect of ASD Severity on ATEC Score
In comparing the difference in LS Mean for ATEC total score at Visit 1, all three pairwise comparisons between severity groups yielded statistically significant differences (Table 10). This is in contrast to Visit 8, at which point none of the comparisons reached statistical significance (Table 10). The results for all four subscales mirrored those of ATEC total score, showing no statistically significant differences between severity groups at Visit 8 (Table 10). This may simply be an artifact of the definition of ASD severity, which is based on a child’s initial ATEC total score. This method groups children with the same initial ATEC total score together independent of age. Thus, children who score 80 on their initial evaluation at the age 10 are grouped together with children who score 80 on their initial evaluation at the age 2. According to ATEC norms (Mahapatra et al. 2018), these children will score 70 and 25 respectively at the age of 12, and therefore clearly belong to different severity groups. This inconsistency in definition of ASD severity solely based on the initial ATEC total score independent of age may explain the observation that none of the group comparisons reached statistical significance at Visit 8.
The definition of ASD severity groups based on two parameters—the initial ATEC total score and age—yielded somewhat superior results compared to defining ASD severity based solely on the initial ATEC total score. While both definition methods showed no statistically significant differences between severity groups at Visit 8 in ATEC total score (Tables 10, 13), the former method showed statistically significant pairwise differences between all the groups at Visit 8 for the Communication subscale, indicating more improvement in children with milder ASD and confirming the advantage of severity group assignment based on both initial ATEC total score and age.
Role of Country of Origin
Conventional wisdom may suggest that the increased access to resources, including government-provided therapy for ASD, should lead to greater improvements. English-speaking nations (the United States, Canada, the United Kingdom, Ireland, Australia, and New Zealand) lead the world in government spending on therapy for children with ASD (Ganz 2007; Horlin et al. 2014; Paula et al. 2011) and therefore would be expected to produce superior outcomes of ASD therapy. Surprisingly, a comparison of English-speaking nations to the non-English-speaking countries demonstrated greater improvements in ATEC total score as well as in each subscale within the non-English speaking nations (Table 8).
This observation runs contrary to conventional thought and underscores the consensus that there is a potential for improving the treatment of children with ASD in the developed world. While it is difficult to speculate on the reason for this disparity between developed English-speaking countries and non-English-speaking countries, it is notable that child treatment is more often outsourced in the developed English-speaking countries compared to more traditional societies where grandparents are more commonly available and mother is more likely to stay at home to personally take care of a child (Fetterolf 2017). Other factors, such as differences in diet (Adams et al. 2018; Rubenstein et al. 2018), reliance on technology (Dunn et al. 2017; Grynszpan et al. 2014; Lorah et al. 2013; Odom et al. 2015; Ploog et al. 2013) and prescription medications (Lemmon et al. 2011) could also play a role.
Limitations
Participant selection presents a novel challenge in a study focused on caregiver-administered assessments. In the selection of participants for inclusion in this study, a baseline of ASD diagnosis could not have been established as child’s diagnosis is not part of ATEC questionnaire. Thus, it is not impossible that some of the participants did not have ASD diagnosis altogether. E.g., parents of a neurotypical toddler worried for any reason about an ASD diagnosis could have decided to monitor toddler’s development with ATEC evaluations and thus inadvertently added their normally developing child to the ATEC collection. As neurotypical children develop faster, the presence of neurotypical children in the dataset would have artificially increased the magnitude of annual changes of ATEC scores, predominantly for younger participants.
It is unlikely though that there were many neurotypical participants in our database. First, ATEC is virtually unknown outside the autism community. Second, there is little incentive for the parents of neurotypical children to complete multiple exhaustive ATEC questionnaires (unless one of the children was previously diagnosed with ASD). Third, as described in the “Methods” section, to further limit the contribution from neurotypical children, participants possibly representing the neurotypical population were excluded: those with an initial ATEC total score of 20 or less (7% of all participants) and those who completed their first evaluation before the age of two (3% of remaining participants). Despite this effort, the reported data may over-approximate the magnitude of annual changes of ATEC scores, especially in the younger participants.
As noted by other groups (Whitehouse et al. 2017; Charman et al. 2004), the use of ATEC as a primary outcome measure has some inherent drawbacks. While the ATEC is capable of delineating incremental differences in ASD severity amongst participants, the variety of measures amongst its subscales fails to differentiate developmental-specific changes from symptom-specific ones. This aspect of the ATEC may introduce a confounding variable when participants are at different developmental stages and follow unique developmental trajectories during a study. To mitigate these effects, trial designs must accurately separate participants based on developmental stage. This is most often accomplished by using age as a proxy for developmental stage.